Latest Breaking News On - Vista pharmaceuticals - Page 13 : comparemela.com

Insider Selling: KalVista Pharmaceuticals, Inc (NASDAQ:KALV) Insider Sells 22,679 Shares of Stock

Insider Selling: KalVista Pharmaceuticals, Inc (NASDAQ:KALV) Insider Sells 22,679 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongEdwardp feenerBarclays plcQuarter for kalvista pharmaceuticalsHong kong ltdNews ratings for kalvista pharmaceuticals dailyKalvista pharmaceuticals price performanceHedge funds weigh in on kalvista pharmaceuticalsRoyal bankKalvista pharmaceuticalsKalvista pharmaceuticals incGet free reportVista pharmaceuticalsKong ltdKalvista pharmaceuticals daily

KalVista Pharmaceuticals, Inc (NASDAQ:KALV) Major Shareholder Venrock Healthcare Capital Par Acquires 17,605 Shares

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 17,605 shares of the stock in a transaction dated Wednesday, January 3rd. The stock was acquired at an average cost of $12.20 per share, with a total value of $214,781.00. Following the completion of the transaction, the insider now owns […]

United statesHong kongRoyal bankQuarter for kalvista pharmaceuticalsKalvista pharmaceuticals incBarclays plcHong kong ltdHedge funds weigh in on kalvista pharmaceuticalsKalvista pharmaceuticals stock performanceKalvista pharmaceuticals company profileNews ratings for kalvista pharmaceuticals dailyKalvista pharmaceuticalsGet free reportVenrock healthcare capital parHealthcare capital parVista pharmaceuticals

KalVista Stock: On Demand Oral Treatment For HAE Signify Differentiated Advancement (KALV)

KalVista Stock: On Demand Oral Treatment For HAE Signify Differentiated Advancement (KALV)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Kansuda kaewwannaratCantor fitzgerald coKalvista pharmaceuticalsTakeda pharmaceuticalsVista pharmaceuticalsHereditary angioedemaPatient global impressionNew drug applicationVisual analogue scoreSales agreementCantor fitzgerald

16 Most Promising Long-Term Stocks According to Analysts

In this piece, we will take a look at the 16 most promising long-term stocks according to analysts. If you want to skip our overview of long term investing, then you can take a look at 5 Most Promising Long-Term Stocks According to Analysts. While investing comes in all sizes and flavors, the one approach […]

United statesBritish columbiaJulian bakerKevinc tangDerrick tang kynamFelix bakerAlta equipment group incRelay therapeutics incMining incEvolus incKalvista pharmaceuticals incZynex incLiquidia corporationSilver corpAltimmune incXperi inc

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterBryan bakerJarrod aldomAndrew crockettExchange commissionCorporate communicationsKalvista pharmaceuticals incKalvista pharmaceuticalsChief executive officerVista pharmaceuticalsSecurities litigation reform actInvestor relationsLassen sie